Evidence map›Paper›PMID 21147226›Full record

ReviewSeminars in cancer biology2011

Transcriptional control of melanoma metastasis: the importance of the tumor microenvironment.

Russell R Braeuer, Maya Zigler, Gabriel J Villares, Andrey S Dobroff, Menashe Bar-Eli

Abstract readReview
In one paragraph

Review in Seminars in cancer biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 87 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Graphene Oxide Normal (GO + MnAntioxidants (Basel, Switzerland) · 2021
    Article
  16. Review
  17. Cell Adhesion Molecules in Plasticity and Metastasis.Molecular cancer research : MCR · 2021
    Review
  18. What turns CREB on? And off? And why does it matter?Cellular and molecular life sciences : CMLS · 2020
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Russell R BraeuerDepartment of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Maya Zigler
Gabriel J Villares
Andrey S Dobroff
Menashe Bar-Eli
The University of Texas MD Anderson Cancer Center · USCentre for Cancer Biology · AU

Funding

TRANSCRIPTION FACTOR AP2 IN METASTASIS OF MELANOMAR01CA076098 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI BARELI, MENASHE · 1999 to 2012
$3.1M
NCI NIH HHS R01 CA076098
6 · The paper itself

Abstract

The molecular changes associated with the transition of melanoma cells from radial growth phase (RGP) to vertical growth phase (VGP) and the metastatic phenotype are not very well defined. However, some of the genes involved in this process and their transcriptional regulation are beginning to be elucidated. For example, the switch from RGP to VGP and the metastatic phenotype is associated with loss of the AP-2α transcription factor. AP-2α regulates the expression of c-KIT, MMP-2, VEGF, and the adhesion molecule MCAM/MUC18. Recently, we reported that AP-2α also regulates two G-protein coupled receptors (GPCRs) PAR-1 and PAFR. In turn, the thrombin receptor, PAR-1, regulates the expression of the gap junction protein Connexin-43 and the tumor suppressor gene Maspin. Activation of PAR-1 also leads to overexpression and secretion of proangiogenic factors such as IL-8, uPA, VEGF, PDGF, as well certain integrins. PAR-1 also cooperates with PAFR to regulate the expression of the MCAM/MUC18 via phosphorylation of CREB. The ligands for these GPCRs, thrombin and PAF, are secreted by stromal cells, emphasizing the importance of the tumor microenvironment in melanoma metastasis. The metastatic phenotype of melanoma is also associated with overexpression and function of CREB/ATF-1. Loss of AP-2α and overexpression of CREB/ATF-1 results in the overexpression of MCAM/MUC18 which by itself contributes to melanoma metastasis by regulating the inhibitor of DNA binding-1 (Id-1). CREB/ATF-1 also regulates the angiogenic factor CYR-61. Our recent data indicate that CREB/ATF-1 regulates the expression of AP-2α, thus, supporting the notion that CREB is an important "master switch" in melanoma progression.

Indexed as

MelanomaTumor MicroenvironmentAnimalsCell Adhesion MoleculesCyclic AMP Response Element-Binding ProteinGene Expression Regulation, NeoplasticHumansNeoplasm MetastasisReceptors, G-Protein-CoupledTranscription Factor AP-2Cell Adhesion MoleculesCyclic AMP Response Element-Binding ProteinReceptors, G-Protein-CoupledTranscription Factor AP-2

Identifiers

PMID21147226
PMCPMC3049824
OpenAlexW2017903142

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.